DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Rational antibiotic therapy and the position of ampicillin/sulbactam.

Author(s): Lode HM

Affiliation(s): Research Centre for Medical Studies, Institute of Clinical Pharmacology, Charite Universitatsmedizin Berlin, Hohenzollerndamm 2, Berlin, Germany. haloheck@zedat.fu-berlin.de

Publication date & source: 2008-07, Int J Antimicrob Agents., 32(1):10-28. Epub 2008 Jun 6.

Publication type: Research Support, Non-U.S. Gov't; Review

In the current context of increasing antimicrobial resistance, it is important to use antibiotics rationally and to re-assess regularly the clinical usefulness of commonly used agents. This review focuses on the efficacy of the beta-lactam ampicillin co-administered with the beta-lactamase inhibitor sulbactam, either parenterally (ampicillin/sulbactam) or orally (sultamicillin), for the treatment of bacterial infections. Clinical findings from the past decade confirm the results of numerous older studies and together provide good evidence to support the continued use of ampicillin/sulbactam and sultamicillin in hospital- and community-acquired infections both in adults and children. This is also recognised in recent published national and international guidelines, many of which recommend ampicillin/sulbactam as first-line therapy for various respiratory and skin infections.

Page last updated: 2008-11-03

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017